2. Geriatrics Flashcards

(21 cards)

1
Q

What are some precipitating factors of acute confusional state (delirium)?

A

Predisposing factors:
- age > 65 years
- background of dementia
- significant injury e.g. NOF
- frailty or multimorbidity
- polypharmacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How can we manage delirium?

A
  • treatment of underlying cause
  • modification of the environment
  • Haloperidol 0.5 mg may be used

In patients with Parkinson’s disease, lorazepam is preferred
or an atypical antipsychotic (e.g. quetiapine, clozapine) may be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why can haloperidol not be used in PD?

A

D2 antagonist
Worsen PD e.g rigidity and risk of NMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the risk factors of developing Alzheimer’s?

A
  • Increasing age
  • Family history
  • Mutations in the amyloid precursor protein (chromosome 21), presenilin 1 (chromosome 14) and presenilin 2 (chromosome 1)
  • Apoprotein E allele E4
  • Caucasian
  • Down’s syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pathophysiology of Alzheimer’s?

A

Macroscopic:
widespread cerebral atrophy, especially
cortex and hippocampus

Microscopic:
- Plaques due to deposition of type A-Beta-amyloid protein
- Intraneuronal neurofibrillary tangles caused by abnormal aggregation of the tau protein due to hyperphosphorylation

Biochemical:
Deficit of acetylcholine from damage to an ascending forebrain projection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is Alzheimer’s managed in primary care?

A

Non-pharmacological management
- Group cognitive stimulation therapy

Pharmacological management
- Acetylcholinesterase inhibitors (donepezil, galantamine and rivastigmine)

  • Memantine (an NMDA receptor antagonist) is second line
  • Review polypharmacy and reduce ACB
  • Antipsychotics only if harming self or hallucinations/agitation causing severe distress, use for shortest period of time e.g 6 weeks

Managing non-cognitive symptoms
- NICE does not recommend antidepressants for mild to moderate depression in patients with dementia
- Assess BPSD symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a contraindication of Donepezil?

A
  • Bradycardia
  • Adverse effects include insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can you distinguish between delirium and dementia?

A

Factors favouring delirium over dementia
- acute onset
- impairment of consciousness
- fluctuation of symptoms: worse at night, periods of normality
- abnormal perception (e.g hallucinations)
- agitation, fear
- delusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should you not prescribe in Lewy Body Dementia?

A

Antipsychotics can worsen the motor features of the condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What investigations should you do for someone if you suspect dementia?

A

- Bloods to exclude reversible causes (e.g. Hypothyroidism) : FBC, U&E, LFTs, calcium, glucose, ESR/CRP, TFTs, vitamin B12 and folate levels

- Neuroimaging to exclude other reversible conditions (e.g. subdural haematoma, normal pressure hydrocephalus)

- Memory clinic for tests e.g MMSE 24 out of 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

On doing a polypharmacy review for a newly diagnosed dementia patient, what medications should you consider stopping?

A

Anticholinergic Cognitive Burden Scale

  • Tricyclic antidepressants e.g amitriptylline
  • Antiemetics e.g metoclopramide
  • Analgesics e.g tramadol
  • Sedatives e.g benzos
  • Antihistamines e.g chlorphenamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the gold standard nemory test for dementia and what score would indicate dementia?

A

ADDENBROOKE’S COGNITIVE EXAM

ACEIII
<82 = dementia
82-88 = mild cognitive impairment

M-ACE
<21 = dementia
21-25 = MCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the three types of FTD and how do they each present differently?

A

Pick’s disease
- Personality change and impaired social conduct
- Focal gyral atrophy with a knife-blade appearance is characteristic

CPA (chronic progressive aphasia)
- Non fluent speech. Short utterances that are agrammatic
- Comprehension is relatively preserved.

Semantic dementia
- Fluent progressive aphasia
- The speech is fluent but empty and conveys little meaning
- Better short than long term memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the microscopic appearance of Pick’s disease?

A
  • Pick bodies - spherical aggregations of tau protein (silver-staining)
  • Gliosis
  • Neurofibrillary tangles
  • Senile plaques
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the common features of FTD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the pathophysiology of Lewy Body Dementia?

A

Alpha-synuclein cytoplasmic inclusions (Lewy bodies) in the substantia nigra, paralimbic and neocortical areas

17
Q

How is LBD diagnosed?

A
  • Usually clinical
  • Single-photon emission computed tomography (SPECT) (a.k.a DaTscan. Dopaminergic iodine-123-radiolabelled)
18
Q

How is LBD managed?

A
  • Acetylcholinesterase inhibitors (e.g. donepezil, rivastigmine) and memantine
  • Avoid antipsychotics
19
Q

What is the inherited form of vascular dementia?

A

CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)

20
Q

How should a diagnosis of vascular dementia be made?

A

NINDS-AIREN criteria

  • Formal screen for cognitive impairment
  • Medical review to exclude medication cause of cognitive decline
  • MRI scan (may show infarcts and extensive white matter changes)
21
Q

How is vascular dementia managed?

A
  • Aaddress cardiovascular risk factors to slow progression
  • Non-pharmacological managemen tailored to the individual
  • Only consider AChE inhibitors or memantine for people with vascular dementia if they have suspected comorbid Alzheimer’s disease, Parkinson’s disease dementia or dementia with Lewy bodies
  • NO evidence for statins or aspirin